Literature DB >> 9557640

Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

A V Nicola1, M Ponce de Leon, R Xu, W Hou, J C Whitbeck, C Krummenacher, R I Montgomery, P G Spear, R J Eisenberg, G H Cohen.   

Abstract

HVEM (for herpesvirus entry mediator) is a member of the tumor necrosis factor receptor superfamily and mediates entry of many strains of herpes simplex virus (HSV) into normally nonpermissive Chinese hamster ovary (CHO) cells. We used sucrose density centrifugation to demonstrate that purified HSV-1 KOS virions bind directly to a soluble, truncated form of HVEM (HVEMt) in the absence of any other cell-associated components. Therefore, HVEM mediates HSV entry by serving as a receptor for the virus. We previously showed that soluble, truncated forms of HSV glycoprotein D (gDt) bind to HVEMt in vitro. Here we show that antibodies specific for gD, but not the other entry glycoproteins gB, gC, or the gH/gL complex, completely block HSV binding to HVEM. Thus, virion gD is the principal mediator of HSV binding to HVEM. To map sites on virion gD which are necessary for its interaction with HVEM, we preincubated virions with gD-specific monoclonal antibodies (MAbs). MAbs that recognize antigenic sites Ib and VII of gD were the only MAbs which blocked the HSV-HVEM interaction. MAbs from these two groups failed to coprecipitate HVEMt in the presence of soluble gDt, whereas the other anti-gD MAbs coprecipitated HVEMt and gDt. Previous mapping data indicated that site VII includes amino acids 11 to 19 and site Ib includes 222 to 252. The current experiments indicate that these sites contain residues important for HSV binding to HVEM. Group Ib and VII MAbs also blocked HSV entry into HVEM-expressing CHO cells. These results suggest that the mechanism of neutralization by these MAbs is via interference with the interaction between gD in the virus and HVEM on the cell. Group Ia and II MAbs failed to block HSV binding to HVEM yet still neutralized HVEM-mediated entry, suggesting that these MAbs block entry at a step other than HVEM binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557640      PMCID: PMC109580          DOI: 10.1128/JVI.72.5.3595-3601.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.

Authors:  V Feenstra; M Hodaie; D C Johnson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.

Authors:  D L Bosch; H J Geerligs; W J Weijer; M Feijlbrief; G W Welling; S Welling-Wester
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Expression and Purification of Secreted Forms of HSV Glycoproteins from Baculovirus-Infected Insect Cells.

Authors:  S H Willis; C Peng; M P Leon; A V Nicola; A H Rux; G H Cohen; R J Eisenberg
Journal:  Methods Mol Med       Date:  1998

5.  ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.

Authors:  H Hsu; I Solovyev; A Colombero; R Elliott; M Kelley; W J Boyle
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

Authors:  D C Johnson; R L Burke; T Gregory
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.

Authors:  T Peng; M Ponce-de-Leon; H Jiang; G Dubin; J M Lubinski; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Herpes simplex virus type 1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan sulfate.

Authors:  W C Lee; A O Fuller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Type-common and type-specific monoclonal antibody to herpes simplex virus type 1.

Authors:  L Pereira; T Klassen; J R Baringer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  74 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Localization of the gD-binding region of the human herpes simplex virus receptor, HveA.

Authors:  J C Whitbeck; S A Connolly; S H Willis; W Hou; C Krummenacher; M Ponce de Leon; H Lou; I Baribaud; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread.

Authors:  D A Rauch; N Rodriguez; R J Roller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Effects of herpes simplex virus on structure and function of nectin-1/HveC.

Authors:  Claude Krummenacher; Isabelle Baribaud; James F Sanzo; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; Don C Wiley; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry.

Authors:  Francesca Cocchi; Daniela Fusco; Laura Menotti; Tatiana Gianni; Roselyn J Eisenberg; Gary H Cohen; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

8.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.

Authors:  Doina Atanasiu; Wan Ting Saw; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

10.  Potential nectin-1 binding site on herpes simplex virus glycoprotein d.

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; J Charles Whitbeck; Yi Zuo; Don C Wiley; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.